Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
AUC prediction
Description:
Prediction of the area under a drug concentration-time curve, a measure of systemic drug exposure used in pharmacokinetics.
Related topics:
Renal Transplantation Outcomes and Treatments (16%),
Pharmaceutical studies and practices (16%),
Pharmacogenetics and Drug Metabolism (16%),
Drug Solubulity and Delivery Systems (7%)
OpenAlex ID:
keywords/auc-prediction
Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
2009
·
Khaled Benkali
, Aurelie Prémaud
, et al.
·
Clinical Pharmacokinetics
·
159
Quantitative Prediction of In Vivo Drug-Drug Interactions from In Vitro Data Based on Physiological Pharmacokinetics: Use of Maximum Unbound Concentration of Inhibitor at the Inlet to the Liver
2000
·
Shin-ichi Kanamitsu
, Kiyomi Ito
, et al.
·
Pharmaceutical Research
·
134
Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies
2012
·
Yuan Chen
, Jin Y. Jin
, et al.
·
Biopharmaceutics & Drug Disposition
·
120
In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models
2016
·
Erik Sjögren
, Helena Thörn
, et al.
·
Molecular Pharmaceutics
·
116
Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information
2022
·
Ha Young Jang
, Jihyeon Song
, et al.
·
npj Digital Medicine
·
80
PDF
IntegratinginvitroADMET data through generic physiologically based pharmacokinetic models
2006
·
David E Leahy
·
Expert Opinion on Drug Metabolism & Toxicology
·
66
Qualitative and Quantitative Assessment of Drug-Drug Interaction Potential in Man, Based on Ki, IC50 and Inhibitor Concentration
2004
·
N. Blanchard
, L. Richert
, et al.
·
Current Drug Metabolism
·
63
Single-point sampling for assessment of constitutive, induced, and inhibited cytochrome P450 3A activity with alfentanil or midazolam
2005
·
H CHAOBAL
, E KHARASCH
·
Clinical Pharmacology & Therapeutics
·
58
Prediction of in Vivo Hepatic Metabolic Clearance of YM796 from in Vitro Data by Use of Human Liver Microsomes and Recombinant P-450 Isozymes
1997
·
Takafumi Iwatsubo
, Hiroshi Suzuki
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
56
Limited Sampling Strategy to Predict AUC of the CYP3A Phenotyping Probe Midazolam in Adults: Application to Various Assay Techniques
2002
·
Jooran S. Kim
, Anne N. Nafziger
, et al.
·
The Journal of Clinical Pharmacology
·
55
PDF
Sandimmune®to neoral®conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients
1999
·
Annemarie Kelles
, Jean Herman
, et al.
·
Pediatric Transplantation
·
51
Integrated in Vitro Analysis for the in Vivo Prediction of Cytochrome P450-Mediated Drug-Drug Interactions
2008
·
Dermot F. McGinnity
, Nigel J. Waters
, et al.
·
Drug Metabolism and Disposition
·
50
Evaluation of a Limited Sampling Strategy to Estimate Area Under the Curve of Tacrolimus in Adult Renal Transplant Patients
2005
·
Yolanda Armend??riz
, Leonor Pou
, et al.
·
Therapeutic Drug Monitoring
·
50
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
2018
·
Jan-Frederik Schlender
, Donato Teutonico
, et al.
·
Clinical Pharmacokinetics
·
47
PDF
Real-time Dose Adjustment of Cyclophosphamide in a Preparative Regimen for Hematopoietic Cell Transplant: A Bayesian Pharmacokinetic Approach
2006
·
David H. Salinger
, Jeannine S. McCune
, et al.
·
Clinical Cancer Research
·
47
Human plasma pharmacokinetics of thiotepa following administration of high-dose thiotepa and cyclophosphamide.
1988
·
S P Ackland
, K E Choi
, et al.
·
Journal of Clinical Oncology
·
45
High-dose melphalan dosage adjustment: possibility of using a test-dose
1989
·
Brigitte Tranchand
, Yves-Dominique Ploin
, et al.
·
Cancer Chemotherapy and Pharmacology
·
40
Projection of Exposure and Efficacious Dose Prior to First-in-Human Studies: How Successful Have We Been?
2007
·
Christine Huang
, Ming Zheng
, et al.
·
Pharmaceutical Research
·
37
Statistical tools for dose individualization of mycophenolic acid and tacrolimus co‐administered during the first month after renal transplantation
2013
·
Flora T. Musuamba
, Michel Mourad
, et al.
·
British Journal of Clinical Pharmacology
·
36
Pharmacokinetic variability and strategy for therapeutic drug monitoring of saquinavir (SQV) in HIV‐1 infected individuals
1999
·
Mario B. Regazzi
, Paola Villani
, et al.
·
British Journal of Clinical Pharmacology
·
33
PDF
Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease
2014
·
Paweł Wiczling
, Robert I. Liem
, et al.
·
The Journal of Clinical Pharmacology
·
32
PDF
Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies
2023
·
Marissa Mock
, Alex W. Jacobitz
, et al.
·
mAbs
·
31
PDF
Population Pharmacokinetic Model to Predict Steady-State Exposure to Once-Daily Cyclosporin Microemulsion in Renal Transplant Recipients
2002
·
Franziska Sch??deli
, Hans-Peter Marti
, et al.
·
Clinical Pharmacokinetics
·
31
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer
1995
·
Michael J. Millward
, David R. Newell
, et al.
·
Cancer Chemotherapy and Pharmacology
·
31
Evaluation of Methods for Predicting Drug-drug Interactions by Monte Carlo Simulation
2003
·
Motohiro Kato
, Tatsuhiko Tachibana
, et al.
·
Drug Metabolism and Pharmacokinetics
·
30
Show more works
View as search
Works count:
146
Citation count:
2,147
Year
Topic
Type